However, in the current study, we identified an activation role of CD95–CD95L axis in tumours and found that blockade of CD95L effectively attenuated TDC-elicited generation of FcγRIIlow/− activated IL-10-producing B cells. The gene discussed is IL10; the disease is neoplasm.